|
1
|
Chu EA and Kim YJ: Laryngeal cancer:
diagnosis and preoperative work-up. Otolaryngol Clin North Am.
41:673–695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tian Y, Fu S, Qiu GB, Xu ZM, Liu N, Zhang
XW, Chen S, Wang Y, Sun KL and Fu WN: MicroRNA-27a promotes
proliferation and suppresses apoptosis by targeting PLK2 in
laryngeal carcinoma. BMC Cancer. 14:6782014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ren J, Zhu D, Liu M, Sun Y and Tian L:
Downregulation of miR-21 modulates Ras expression to promote
apoptosis and suppress invasion of Laryngeal squamous cell
carcinoma. Eur J Cancer. 46:3409–3416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rudolph E, Dyckhoff G, Becher H, Dietz A
and Ramroth H: Effects of tumour stage, comorbidity and therapy on
survival of laryngeal cancer patients: A systematic review and a
meta-analysis. Eur Arch Otorhinolaryngol. 268:165–179. 2011.
View Article : Google Scholar
|
|
5
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhuang LK, Xu GP, Pan XR, Lou YJ, Zou QP,
Xia D, Yan WW, Zhang YT, Jia PM and Tong JH: MicroRNA-181a-mediated
downregulation of AC9 protein decreases intracellular cAMP level
and inhibits ATRA-induced APL cell differentiation. Cell Death Dis.
5:e11612014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
9
|
Shen Z, Zhan G, Ye D, Ren Y, Cheng L, Wu Z
and Guo J: MicroRNA-34a affects the occurrence of laryngeal
squamous cell carcinoma by targeting the antiapoptotic gene
survivin. Med Oncol. 29:2473–2480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tian L, Li M, Ge J, Guo Y, Sun Y, Liu M
and Xiao H: miR-203 is downregulated in laryngeal squamous cell
carcinoma and can suppress proliferation and induce apoptosis of
tumours. Tumour Biol. 35:5953–5963. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yungang W, Xiaoyu L, Pang T, Wenming L and
Pan X: miR-370 targeted FoxM1 functions as a tumor suppressor in
laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother.
68:149–154. 2014. View Article : Google Scholar
|
|
12
|
He Z, Yi J, Liu X, Chen J, Han S, Jin L,
Chen L and Song H: miR-143-3p functions as a tumor suppressor by
regulating cell proliferation, invasion and epithelial-mesenchymal
transition by targeting QKI-5 in esophageal squamous cell
carcinoma. Mol Cancer. 15:512016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li D, Hu J, Song H, Xu H, Wu C, Zhao B,
Xie D, Wu T, Zhao J and Fang L: miR-143-3p targeting LIM domain
kinase 1 suppresses the progression of triple-negative breast
cancer cells. Am J Transl Res. 9:2276–2285. 2017.PubMed/NCBI
|
|
14
|
Campbell SL, Khosravi-Far R, Rossman KL,
Clark GJ and Der CJ: Increasing complexity of Ras signaling.
Oncogene. 17(11 Reviews): 1395–1413. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vojtek AB and Der CJ: Increasing
complexity of the Ras signaling pathway. J Biol Chem.
273:19925–19928. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Campbell PM, Groehler AL, Lee KM,
Ouellette MM, Khazak V and Der CJ: K-Ras promotes growth
transformation and invasion of immortalized human pancreatic cells
by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res.
67:2098–2106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim MJ, Woo SJ, Yoon CH, Lee JS, An S,
Choi YH, Hwang SG, Yoon G and Lee SJ: Involvement of autophagy in
oncogenic K-Ras-induced malignant cell transformation. J Biol Chem.
286:12924–12932. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Voice JK, Klemke RL, Le A and Jackson JH:
Four human ras homologs differ in their abilities to activate
Raf-1, induce transformation, and stimulate cell motility. J Biol
Chem. 274:17164–17170. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maehara Y, Saeki H and Morita M: Molecular
mechanisms of esophageal squamous cell carcinogenesis: Clues to
improve treatment outcomes. Ann Thorac Cardiovasc Surg. 16:387–388.
2010.
|
|
20
|
Keohavong P, Mady HH, Gao WM, Siegfried
JM, Luketich JD and Melhem MF: Topographic analysis of K-ras
mutations in histologically normal lung tissues and tumours of lung
cancer patients. Br J Cancer. 85:235–241. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karnoub AE and Weinberg RA: Ras oncogenes:
Split personalities. Nat Rev Mol Cell Biol. 9:517–531. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pylayeva-Gupta Y, Grabocka E and Bar-Sagi
D: RAS oncogenes: Weaving a tumorigenic web. Nat Rev Cancer.
11:761–774. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Samatar AA and Poulikakos PI: Targeting
RAS-ERK signalling in cancer: Promises and challenges. Nat Rev Drug
Discov. 13:928–942. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cox AD, Fesik SW, Kimmelman AC, Luo J and
Der CJ: Drugging the undruggable RAS: Mission possible? Nat Rev
Drug Discov. 13:828–851. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hatley ME, Patrick DM, Garcia MR,
Richardson JA, Bassel-Duby R, van Rooij E and Olson EN: Modulation
of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell.
18:282–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou K, Luo X, Wang Y, Cao D and Sun G:
MicroRNA-30a suppresses tumor progression by blocking
Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
Biomed Pharmacother. 93:1025–1032. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou L, Rui JA, Ye DX, Wang SB, Chen SG
and Qu Q: Edmondson-Steiner grading increases the predictive
efficiency of TNM staging for long-term survival of patients with
hepatocellular carcinoma after curative resection. World J Surg.
32:1748–1756. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma J, Ren Y, Zhang L, Kong X, Wang T, Shi
Y and Bu R: Knocking-down of CREPT prohibits the progression of
oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc
expression. PLoS One. 12:e01743092017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Δ ΔC(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
30
|
Lai YJ, Lin CI, Wang CL and Chao JI:
Expression of survivin and p53 modulates honokiol-induced apoptosis
in colorectal cancer cells. J Cell Biochem. 115:1888–1899.
2014.PubMed/NCBI
|
|
31
|
Schipper JH, Frixen UH, Behrens J, Unger
A, Jahnke K and Birchmeier W: E-cadherin expression in squamous
cell carcinomas of head and neck: Inverse correlation with tumor
dedifferentiation and lymph node metastasis. Cancer Res.
51:6328–6337. 1991.PubMed/NCBI
|
|
32
|
Gotoda T, Yanagisawa A, Sasako M, Ono H,
Nakanishi Y, Shimoda T and Kato Y: Incidence of lymph node
metastasis from early gastric cancer: Estimation with a large
number of cases at two large centers. Gastric Cancer. 3:219–225.
2000. View Article : Google Scholar
|
|
33
|
Hartgrink HH, van de Velde CJ, Putter H,
Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken
JH, Meijer S, Plukker JT, et al: Extended lymph node dissection for
gastric cancer: Who may benefit? Final results of the randomized
Dutch gastric cancer group trial. J Clin Oncol. 22:2069–2077. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bergers G, Brekken R, McMahon G, Vu TH,
Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, et al:
Matrix metallopro-teinase-9 triggers the angiogenic switch during
carcinogenesis. Nat Cell Biol. 2:737–744. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Natalwala A, Spychal R and Tselepis C:
Epithelial-mesenchymal transition mediated tumourigenesis in the
gastrointestinal tract World. J Gastroenterol. 14:3792–3797.
2008.
|
|
37
|
Eriksen JG, Steiniche T, Sogaard H and
Overgaard J: Expression of integrins and E-cadherin in squamous
cell carcinomas of the head and neck. APMIS. 112:560–568. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang SY, Lu ZM, Lin YF, Chen LS, Luo XN,
Song XH, Chen SH and Wu YL: miR-144-3p, a tumor suppressive
microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.
Oncotarget. 7:11637–11650. 2016.PubMed/NCBI
|
|
39
|
Schmalhofer O, Brabletz S and Brabletz T:
E-cadherin, beta-catenin, and ZEB1 in malignant progression of
cancer. Cancer Metastasis Rev. 28:151–166. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li JZ, Gao W, Lei WB, Zhao J, Chan JY, Wei
WI, Ho WK and Wong TS: MicroRNA 744-3p promotes MMP-9-mediated
metastasis by simultaneously suppressing PDCD4 and PTEN in
laryngeal squamous cell carcinoma. Oncotarget. 7:58218–58233.
2016.PubMed/NCBI
|
|
41
|
Zhang W, Liu Y and Wang CW: S100A4
promotes squamous cell laryngeal cancer Hep-2 cell invasion via
NF-κB/MMP-9 signal. Eur Rev Med Pharmacol Sci. 18:1361–1367.
2014.
|
|
42
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar :
|
|
43
|
Han Z, Yang Q, Liu B, Wu J, Li Y, Yang C
and Jiang Y: MicroRNA-622 functions as a tumor suppressor by
targeting K-Ras and enhancing the anticarcinogenic effect of
resveratrol. Carcinogenesis. 33:131–139. 2012. View Article : Google Scholar
|
|
44
|
Zhai W, Sun Y, Guo C, Hu G, Wang M, Zheng
J, Lin W, Huang Q, Li G, Zheng J, et al: lncRNA-SARCC suppresses
renal cell carcinoma (RCC) progression via altering the androgen
receptor(AR)/miRNA-143-3p signals. Cell Death Differ. 24:1502–1517.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ramos JW: The regulation of extracellular
signal-regulated kinase (ERK) in mammalian cells. Int J Biochem
Cell Biol. 40:2707–2719. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
McCubrey JA, Steelman LS, Chappell WH,
Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M,
Tafuri A, et al: Roles of the Raf/MEK/ERK pathway in cell growth,
malignant transformation and drug resistance. Biochim Biophys Acta.
1773:1263–1284. 2007. View Article : Google Scholar
|
|
47
|
Zhang X, Mao H, Chen JY, Wen S, Li D, Ye M
and Lv Z: Increased expression of microRNA-221 inhibits PAK1 in
endothelial progenitor cells and impairs its function via
c-Raf/MEK/ERK pathway. Biochem Biophys Res Commun. 431:404–408.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Coburn GA and Cullen BR: siRNAs: A new
wave of RNA-based therapeutics. J Antimicrob Chemother. 51:753–756.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cheng EH, Wei MC, Weiler S, Flavell RA,
Mak TW, Lindsten T and Korsmeyer SJ: BCL-2, BCL-X(L) sequester BH3
domain-only molecules preventing BAX- and BAK-mediated
mitochondrial apoptosis. Mol Cell. 8:705–711. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ochs K and Kaina B: Apoptosis induced by
DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and
Fas/caspase-8 independent. Cancer Res. 60:5815–5824.
2000.PubMed/NCBI
|
|
51
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jou J and Diehl AM: Epithelial-mesenchymal
transitions and hepatocarcinogenesis. J Clin Invest. 120:1031–1034.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gou X, Chen H, Jin F, Wu W, Li Y, Long J,
Gong X, Luo M, Bi T, Li Z, et al: Expressions of CD147, MMP-2 and
MMP-9 in laryngeal carcinoma and its correlation with poor
prognosis. Pathol Oncol Res. 20:475–481. 2014. View Article : Google Scholar
|
|
54
|
Malumbres M and Barbacid M: RAS oncogenes:
The first 30 years. Nat Rev Cancer. 3:459–465. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shimizu K, Goldfarb M, Suard Y, Perucho M,
Li Y, Kamata T, Feramisco J, Stavnezer E, Fogh J and Wigler MH:
Three human transforming genes are related to the viral ras
oncogenes. Proc Natl Acad Sci USA. 80:2112–2116. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Davies H, Bignell GR, Cox C, Stephens P,
Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W,
et al: Mutations of the BRAF gene in human cancer. Nature.
417:949–954. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Alavi A, Hood JD, Frausto R, Stupack DG
and Cheresh DA: Role of Raf in vascular protection from distinct
apoptotic stimuli. Science. 301:94–96. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hood JD, Bednarski M, Frausto R, Guccione
S, Reisfeld RA, Xiang R and Cheresh DA: Tumor regression by
targeted gene delivery to the neovasculature. Science.
296:2404–2407. 2002. View Article : Google Scholar : PubMed/NCBI
|
